1. Home
  2. SGHT vs BWFG Comparison

SGHT vs BWFG Comparison

Compare SGHT & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • BWFG
  • Stock Information
  • Founded
  • SGHT 2011
  • BWFG 2002
  • Country
  • SGHT United States
  • BWFG United States
  • Employees
  • SGHT N/A
  • BWFG N/A
  • Industry
  • SGHT Medical Specialities
  • BWFG Major Banks
  • Sector
  • SGHT Health Care
  • BWFG Finance
  • Exchange
  • SGHT Nasdaq
  • BWFG Nasdaq
  • Market Cap
  • SGHT 304.4M
  • BWFG 256.5M
  • IPO Year
  • SGHT 2021
  • BWFG N/A
  • Fundamental
  • Price
  • SGHT $3.54
  • BWFG $30.86
  • Analyst Decision
  • SGHT Buy
  • BWFG Buy
  • Analyst Count
  • SGHT 7
  • BWFG 1
  • Target Price
  • SGHT $6.27
  • BWFG $40.00
  • AVG Volume (30 Days)
  • SGHT 234.0K
  • BWFG 14.4K
  • Earning Date
  • SGHT 11-07-2024
  • BWFG 01-22-2025
  • Dividend Yield
  • SGHT N/A
  • BWFG 2.50%
  • EPS Growth
  • SGHT N/A
  • BWFG N/A
  • EPS
  • SGHT N/A
  • BWFG 1.94
  • Revenue
  • SGHT $79,543,000.00
  • BWFG $72,009,000.00
  • Revenue This Year
  • SGHT $2.18
  • BWFG N/A
  • Revenue Next Year
  • SGHT $8.14
  • BWFG $9.07
  • P/E Ratio
  • SGHT N/A
  • BWFG $16.46
  • Revenue Growth
  • SGHT N/A
  • BWFG N/A
  • 52 Week Low
  • SGHT $3.16
  • BWFG $22.47
  • 52 Week High
  • SGHT $8.45
  • BWFG $35.25
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 36.40
  • BWFG 38.98
  • Support Level
  • SGHT $3.52
  • BWFG $30.43
  • Resistance Level
  • SGHT $3.73
  • BWFG $32.87
  • Average True Range (ATR)
  • SGHT 0.20
  • BWFG 0.75
  • MACD
  • SGHT 0.01
  • BWFG -0.38
  • Stochastic Oscillator
  • SGHT 24.54
  • BWFG 5.83

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About BWFG Bankwell Financial Group Inc.

Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses, and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.

Share on Social Networks: